Try our Advanced Search for more refined results
Searching dockets in Alembic 3 x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Notice of Service
NOTICE OF SERVICE of (1) Plaintiff Novartis Pharmaceuticals Corporation's Amended First Supplemental Objections and Responses to Defendants MSN Pharmaceuticals Inc., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, and Novadoz Pharmaceuticals, LLC's First Set of Interrogatories to Plaintiffs Novartis Pharmaceuticals Corporation (Nos. 1-16); and (2) Novartis's Amended First Supplemental Objections and Responses to Defendants MSN Pharmaceuticals Inc., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, and Novadoz Pharmaceuticals, LLC's Second Set of Interrogatories (No. 17) to Plaintiffs Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra)
Add Attorneys - PHV only
Pro Hac Vice Attorney Falicia C. Elenberg for Array BioPharma Inc., Bayer Consumer Care AG, Bayer HealthCare LLC, Bayer HealthCare Pharmaceuticals Inc., and Loxo Oncology, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
Phone
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 UK may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.